This content is for members only. Visit the site and log in/register to read.

MEPs give overwhelming backing to a new EU cardiovascular strategy, placing alcohol, food and tobacco policy at the heart of a wider drive to tackle Europe’s biggest killer

The European Parliament has given overwhelming backing to a new EU cardiovascular diseases strategy, with 545 MEPs voting in favour of a report that places prevention at the centre of Europe’s response to its biggest cause of death.

The vote marks a significant political endorsement of a broader approach to cardiovascular health, addressing not only diagnosis and treatment but also the major lifestyle and consumer-related risk factors associated with cardiovascular disease.

Three sectors feature prominently in that debate: alcohol, food and tobacco and nicotine products.

Rather than relying on a single regulatory approach, Parliament’s position points towards a combination of education, consumer information, prevention, proportionate regulation and measures targeted at clearly identified health risks.

Cardiovascular diseases remain the leading cause of mortality in the European Union, accounting for around 1.7 million deaths every year. Around 62 million people are living with cardiovascular disease in the EU, while close to 13 million new cases occur annually.

An estimated 80% of cardiovascular disease, including many cases of heart disease and stroke, is considered preventable.

Those figures have transformed cardiovascular disease from primarily a healthcare issue into a much broader European policy challenge.

The adopted report therefore addresses prevention alongside screening, early detection, treatment and care.

Alcohol: focusing on harmful consumption

Alcohol is one of the major modifiable risk factors identified in cardiovascular prevention.

A central issue in the European debate is how to distinguish between policies aimed at harmful alcohol consumption and measures that treat all drinking patterns in essentially the same way.

That distinction matters in a European Union where national traditions, consumption patterns and regulatory approaches vary considerably.

Measures under discussion include greater public awareness of alcohol-related health risks and better consumer information.

The cardiovascular debate consequently reinforces a wider movement towards giving consumers clearer information about the possible health consequences associated with excessive alcohol consumption.

At the same time, Parliament’s approach leaves room for the principle of proportionality.

The policy challenge is not simply whether alcohol consumption can contribute to cardiovascular risk — the scientific relationship is well established — but which regulatory measures are most effective in reducing harmful consumption without imposing measures that are disproportionate to the objective.

That distinction is likely to remain important as the EU develops its wider strategy on non-communicable diseases.

Food: healthier choices rather than simplistic classifications

Food and nutrition represent another major strand of cardiovascular prevention.

Obesity, excessive salt intake, poor diet and high consumption of certain highly processed foods can all contribute to cardiovascular risk.

That has inevitably placed the food industry at the centre of the debate.

But regulating food is fundamentally different from regulating products whose consumption is inherently associated with health risk.

Individual foods form part of much broader diets, while quantity, frequency of consumption, nutritional composition and lifestyle all influence health outcomes.

The Parliament report therefore places considerable emphasis on enabling Europeans to make better-informed choices.

Public-health education and clearer nutritional information are among the principal tools available.

Front-of-pack food labelling is also part of the wider European discussion over how consumers can be given easily understandable nutritional information.

However, that issue remains politically sensitive.

Any European system must operate across very different national diets and food traditions while avoiding labels that oversimplify nutritional science or inadvertently discourage otherwise balanced eating patterns.

The economic implications are equally significant.

Europe’s food and agricultural sectors are major employers and central components of the Single Market.

Future cardiovascular policy therefore has to reconcile public health, consumer information, agricultural interests, competitiveness and Europe’s diverse food cultures.

Tobacco and nicotine: prevention alongside risk differentiation

The third major area covered by the cardiovascular debate is tobacco and nicotine.

Smoking is a significant preventable contributor to cardiovascular disease, and Parliament’s report supports measures aimed at reducing smoking and preventing young people from beginning to use tobacco and nicotine products.

There is particularly strong emphasis on protecting minors.

The report supports effective enforcement of minimum-age-of-sale requirements and appropriate identification checks whether products are purchased in physical shops or online.

At the same time, Parliament has introduced an important element of differentiation into the debate.

The adopted approach recognises that different nicotine products may have differentiated risk profiles, rather than automatically treating every tobacco and nicotine product as presenting an identical risk.

The supplied policy material also records Parliament’s support for appropriate and differentiated excise taxation between different product categories.  It combines calls for tighter rules with an explicit nod to the idea that regulation need not be one-size-fits-all across the nicotine market.

That distinction could have consequences beyond cardiovascular policy.

The European Commission is already examining the future of the Tobacco Products Directive (TPD) and Tobacco Advertising Directive (TAD), meaning EP’s approach to differentiated risks is likely to be closely watched as the EU considers regulation of cigarettes, heated tobacco products, electronic cigarettes, nicotine pouches and other products.

But the cardiovascular report simultaneously makes clear that protecting children and young people remains an overarching objective irrespective of the particular product involved.

The question of consistency

The debate will not end with the cardiovascular vote.

Parliament is simultaneously considering other major health-policy files, particularly those associated with Europe’s Beating Cancer Plan (BECA).

That creates an important question of policy consistency.

Alcohol, food and tobacco appear repeatedly in European strategies dealing with non-communicable disease.

Positions adopted in one parliamentary report will inevitably therefore be compared with those adopted in another.

The briefing accompanying the cardiovascular debate already highlights this issue, arguing that potentially contradictory approaches between the cardiovascular and cancer files could create uncertainty about Parliament’s wider regulatory direction.

That discussion is likely to intensify as Parliament and the Commission move from broad public-health strategies towards individual regulatory measures.

For the alcohol, food and tobacco sectors alike, the key question will be whether Europe develops policies that are evidence-based, proportionate and tailored to the particular risks involved, rather than attempting to impose identical regulatory solutions across fundamentally different industries.

After two clear defeats, the TED opinion and the CVD Report, the EC is seeking a comeback through BECA, despite the EP's opposition to extreme prohibitionist measures. With EP’S SANT Committee vote due on 28 September, BECA is rapidly becoming the next political battleground.

Prevention becomes mainstream EU policy

Cardiovascular disease imposes immense human and economic costs on Europe through premature deaths, long-term illness, disability, hospital treatment and lost productivity.

Reducing that burden will require healthcare systems to diagnose and treat disease earlier.

But Parliament’s vote also sends a wider message.

Improving cardiovascular health will require action long before people reach hospitals or doctors’ surgeries.

The debate over alcohol, food and tobacco is therefore part of a much larger European question: how public authorities can help citizens reduce preventable health risks while preserving proportionality, informed consumer choice and regulatory coherence.